The global cardiovascular and soft tissue repair patches market size was valued at USD 3.7 billion in 2020, and is predicted to be worth around USD 7.7 billion by 2030, registering a CAGR of 8.4% during the forecast period 2022 to 2030.
Growth Factors
The rapidly rising prevalence of congenital heart diseases, such as Atrial Septal Defect (ASD)and the ventricular septal defect is expected to drive the demand for the patches. In addition, increasing implementation of patches in medical procedures and growing sports injuries is expected to support the development and growth of the market over the forthcoming years. As per studies, ASD is the second most common type of congenital heart disease and the incidence rate across the global population is recorded to be 56 per 100,000 live births.
One of the key driving market forces is the rapidly rising prevalence of cardiovascular diseases. Changing lifestyles, growing obesity levels, adoption of unhealthy lifestyle habits, increasing alcohol consumption and smoking, and growing geriatric population are driving the incidence of cardiac disorders.
The rapidly rising incidence rate of congenital heart diseases across the globe is driving the development & growth of the market. As per data estimates on congenital heart diseases published by Centers for Disease Control and Prevention, congenital heart diseases impact nearly 1% or 40,000 live births annually in the U.S. Atrial Septal Defect (ASD) and ventricular septal defect are the two commonest congenital heart diseases.
Report Coverage
Report Scope | Details |
Market Size | US$ 7.7 billion by 2030 |
Growth Rate | CAGR of 8.4% From 2022 to 2030 |
Largest Market | North America |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segments Covered | Application, Raw material |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Companies Mentioned | Baxter; Admedus; Abbott; LeMaitre Vascular Inc.; Edwards Life Sciences Corporation; Glycar SA Pty Ltd.; LabCor; Cryolife, Inc.; CorMatrix; Terumo Medical Corporation; Bard Peripheral Vascular Inc.; Neovasc; W.L. Gore & Associates, Inc.; B.Braun; Novomedics; TEI Biosciences Inc.; Perouse Medical; Gunze Limited; Atriummed; Maverick Bioscience; Southern Lights Biomaterials |
By Application Analysis
The soft tissue segment dominated the market for cardiovascular and soft tissue repair patches and accounted for the largest revenue share of 42.0% in 2021. This is owing to the rapidly growing incidence rate of hernias including ventral hernias, umbilical hernia, inguinal hernia, congenital diaphragmatic hernia, and others coupled with the growing demand for tissue repair patches in treatment procedures.
On the other hand, the cardiac repair segment is anticipated to register the fastest growth rate in the market for cardiovascular and soft tissue repair patches over the forthcoming years. This is owing to the alarming rise of congenital heart diseases amongst the global pediatric population driving the demand for cardiac patches.
By Raw Material Analysis
The Eptfe segment dominated the cardiovascular and soft tissue repair patches market and accounted for the largest revenue share of 61.4% in 2021. This growth of the segment is owing to the multiple benefits associated with ePTFE such as high tensile strength, high durability, and easy availability.
The widespread application of ePTFE in manufacturing medical accessories such as wound care materials, transducer protectors, ostomy bags, face masks, drainage bags, urine bags, and medical device enclosures. On the other hand, the biomaterial and tissue engineered material segment is anticipated to register the fastest growth rate in the market for cardiovascular and soft tissue repair patches over the forthcoming years.
The most commonly used raw material in manufacturing cardiovascular and soft tissue repair patches is bovine pericardium and is gaining popularity. Bovine pericardium offers several physical and chemical properties which is boosting the adoption of the same.
By Regional Analysis
North America dominated the market for cardiovascular and soft tissue repair patches and accounted for the largest revenue share of 37.6% in 2021. This is owing to rapidly changing lifestyles, growing prevalence of cardiac diseases, rising number of hernia disorders, increasing alcohol consumption and smoking, growing obesity levels, and rising substance abuse.
Asia Pacific is anticipated to register the fastest growth rate over the forthcoming years owing to the rapid advancements in healthcare infrastructure, growing trends of minimally invasive surgical procedures, rising incidence of cardiac disease, growing medical tourism, rapid economic development in several countries such as China and India, growing geriatric population, and rising burden of chronic disorders.
Key Players
Baxter
Admedus
Abbott
LeMaitre Vascular Inc.
Edwards Life Sciences Corporation
Glycar SA Pty Ltd.
LabCor
Cryolife, Inc.
CorMatrix
Terumo Medical Corporation
Bard Peripheral Vascular Inc.
Neovasc
W.L. Gore & Associates, Inc.
B.Braun
Novomedics
TEI Biosciences Inc.
Perouse Medical
Gunze Limited
Atriummed
Maverick Bioscience
Southern Lights Biomaterials
Market Segmentation
By Application
Cardiac repair
Atrial septal defect
Common atrium
Defects of the endocardial cushion
Ventricular septal defect
Tetralogy of Fallot
Right ventricular outflow tract reconstruction
Suture bleeding
Vascular repair & reconstruction
Carotid endarterectomy
Anomalous connection of the pulmonary veins
Transposition of the great vessels
Reconstruction of portal and superior mesenteric veins
Other Vascular repair and reconstruction
Pericardial repair
Dural repair
Soft Tissue repair
Defects of the abdominal wall
Defects of the thoracic wall
Gastric binding
Hernias
By Raw Materials
ePTFE
Biomaterial and tissue engineered material
Others
Regional
North America
U.S.
Canada
Europe
U.K.
Germany
Spain
France
Italy
Russia
Asia Pacific
China
Japan
India
South Korea
Singapore
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Saudi Arabia
UAE
South Africa
The cardiovascular and soft tissue repair patches market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of cardiovascular and soft tissue repair patches market for the base year 2021 and the forecast between 2022 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global cardiovascular and soft tissue repair patches market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the cardiovascular and soft tissue repair patches market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted cardiovascular and soft tissue repair patches market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the cardiovascular and soft tissue repair patches capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of cardiovascular and soft tissue repair patches by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global cardiovascular and soft tissue repair patches market. These figures have been provided in terms of both revenue and volume for the period 2019 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major cardiovascular and soft tissue repair patches market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of cardiovascular and soft tissue repair patches market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the cardiovascular and soft tissue repair patches industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
cardiovascular and soft tissue repair patches market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to cardiovascular and soft tissue repair patches market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of cardiovascular and soft tissue repair patches market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new cardiovascular and soft tissue repair patches market. These factors have benefited the growth of the global market for cardiovascular and soft tissue repair patches. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for cardiovascular and soft tissue repair patches. The global market is segmented on the basis of region, application, end-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of cardiovascular and soft tissue repair patches are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Cardiovascular And Soft Tissue Repair Patches Market, By Application
7.1. Cardiovascular And Soft Tissue Repair Patches Market, by Application, 2021-2030
7.1.1. Cardiac repair
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Vascular repair & reconstruction
7.1.2.1. Market Revenue and Forecast (2019-2030)
7.1.3. Pericardial repair
7.1.3.1. Market Revenue and Forecast (2019-2030)
7.1.4. Dural repair
7.1.4.1. Market Revenue and Forecast (2019-2030)
7.1.5. Soft Tissue repair
7.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global Cardiovascular And Soft Tissue Repair Patches Market, By Raw Material
8.1. Cardiovascular And Soft Tissue Repair Patches Market, by Raw Material, 2021-2030
8.1.1. ePTFE
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Biomaterial and tissue engineered material
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Cardiovascular And Soft Tissue Repair Patches Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Application (2019-2030)
9.1.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Application (2019-2030)
9.1.3.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Application (2019-2030)
9.1.4.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Application (2019-2030)
9.2.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Application (2019-2030)
9.2.3.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Application (2019-2030)
9.2.4.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Application (2019-2030)
9.2.5.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Application (2019-2030)
9.2.6.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Application (2019-2030)
9.3.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Application (2019-2030)
9.3.3.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Application (2019-2030)
9.3.4.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Application (2019-2030)
9.3.5.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Application (2019-2030)
9.3.6.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Application (2019-2030)
9.4.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Application (2019-2030)
9.4.3.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Application (2019-2030)
9.4.4.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Application (2019-2030)
9.4.5.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Application (2019-2030)
9.4.6.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Application (2019-2030)
9.5.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Application (2019-2030)
9.5.3.2. Market Revenue and Forecast, by Raw Material (2019-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Application (2019-2030)
9.5.4.2. Market Revenue and Forecast, by Raw Material (2019-2030)
Chapter 10. Company Profiles
10.1. Baxter
10.1.1. Company Overview
10.1.2. Application Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Admedus
10.2.1. Company Overview
10.2.2. Application Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Abbott
10.3.1. Company Overview
10.3.2. Application Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. LeMaitre Vascular Inc.
10.4.1. Company Overview
10.4.2. Application Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Edwards Life Sciences Corporation
10.5.1. Company Overview
10.5.2. Application Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Glycar SA Pty Ltd.
10.6.1. Company Overview
10.6.2. Application Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. LabCor
10.7.1. Company Overview
10.7.2. Application Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Cryolife, Inc.
10.8.1. Company Overview
10.8.2. Application Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. CorMatrix
10.9.1. Company Overview
10.9.2. Application Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Terumo Medical Corporation
10.10.1. Company Overview
10.10.2. Application Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms